Journal Logo

Erratum

Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment: Erratum

Author Information
doi: 10.1097/MD.0000000000020260
  • Open

In the article, “Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment”,[1] which appears in Volume 98, Issue 30 of Medicine, the statement “The authors have no conflicts of interests to disclose” should appear as “ should appear as “The authors received assistance with the article processing charge from myTomorrows (Impatients N.V. company).”

Reference

[1]. Merdin A, İskender D, Ulu BU. Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment. Medicine. 2019 98;e16482.
Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc.